Gsa Capital Partners LLP Axogen, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	BUY	$3.61 - $7.76 $225,924 - $485,644	62,583 New	62,583 $427,000
Q2 2022 Aug 09, 2022	SELL	$6.99 - $10.0 $121,612 - $173,980	-17,398 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$7.26 - $10.7 $126,309 - $186,158	17,398 New	17,398 $138,000
Q3 2021 Nov 12, 2021	SELL	$15.23 - $21.72 $225,129 - $321,065	-14,782 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$17.8 - $23.5 $263,119 - $347,377	14,782 New	14,782 $319,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.